Clinical trials
Recherche d’études cliniques
Recherchez uniquement dans les études cliniques enregistrées dans Biomedical Watch.
Études cliniques 574
| Étude / NCT ⇅ | Molécule ⇅ | Maladie ⇅ | Phase ⇅ | Statut ⇅ | Résultat ⇅ | Sponsor ⇅ | Pays / centres ⇅ | Période ⇅ | Détail |
|---|---|---|---|---|---|---|---|---|---|
| NCT07156227 Testing the Addition of an Anti-Cancer Drug, Camonsertib, to Radiation … |
Biospecimen Collection | Cancer | Phase 1 | RECRUITING | En attente / non publié | National Cancer Institute (NCI) | United States · City of Hope at Irvine Lennar, Irvine… | 2027-02-13 → 2029-05-31 | Ouvrir |
| NCT06727565 VELOCITY-HNSCC — Study of Novel Treatment Combination Therapies in Part… |
Domvanalimab | Cancer | Phase 2 | ACTIVE_NOT_RECRUITING | En attente / non publié | Gilead Sciences | United States, Australia, China, France, Italy, Malay… | 2025-02-18 → 2027-03 | Ouvrir |
| NCT04246177 Safety and Efficacy of Lenvatinib (E7080/MK-7902) With Pembrolizumab (M… |
Lenvatinib | Cancer | Phase 3 | TERMINATED | En attente / non publié | Zhejiang University | United States, Australia, Brazil, Chile, China, Colom… | 2020-05-22 → 2026-03-26 | Ouvrir |
| NCT06203600 Adding Nivolumab to Usual Treatment for People With Advanced Stomach or… |
Biospecimen Collection | Cancer | Phase 2/3 | RECRUITING | En attente / non publié | National Cancer Institute (NCI) | United States · Abbott-Northwestern Hospital, Minneap… | 2024-06-24 → 2027-10-31 | Ouvrir |
| NCT06084936 GLOBRYTE — A Study to Evaluate Glofitamab as a Single Agent vs. Investi… |
Obinutuzumab | Cancer | Phase 3 | RECRUITING | En attente / non publié | M.D. Anderson Cancer Center | United States, Australia, Brazil, Canada, China, Fran… | 2023-10-22 → 2028-03-31 | Ouvrir |
| NCT06337318 Comparing Rituximab and Mosunetuzumab Drug Treatments for People With L… |
Biospecimen Collection | Cancer | Phase 3 | RECRUITING | En attente / non publié | National Cancer Institute (NCI) | United States · Abbott-Northwestern Hospital, Minneap… | 2024-10-23 → 2032-03-31 | Ouvrir |
| NCT06064097 A Study Using Nivolumab, in Combination With Chemotherapy Drugs to Trea… |
Biopsy Procedure | Cancer | Phase 2 | RECRUITING | En attente / non publié | National Cancer Institute (NCI) | United States, Australia, Canada, New Zealand, Puerto… | 2024-06-25 → 2027-03-31 | Ouvrir |
| NCT06136624 OMAHA-003 — Study of Opevesostat (MK-5684) Versus Alternative NHA in mC… |
Opevesostat | Cancer | Phase 3 | RECRUITING | En attente / non publié | Merck Sharp & Dohme LLC | United States, Argentina, Australia, Austria, Brazil,… | 2023-12-31 → 2030-02-15 | Ouvrir |
| NCT07491497 A Phase 1/2 Study of TRI-611 in ALK-Positive NSCLC |
TRI-611 | Cancer | Phase 1/2 | RECRUITING | En attente / non publié | TRIANA Biomedicines, Inc. | United States, Australia · Dana Farber Cancer Center,… | 2026-03-11 → 2034-01-30 | Ouvrir |
| NCT06790693 INAVO123 — A Study Evaluating the Efficacy and Safety of Inavolisib Plu… |
Inavolisib | Cancer | Phase 3 | RECRUITING | En attente / non publié | Hoffmann-La Roche | United States, Argentina, Australia, Brazil, Canada, … | 2025-04-09 → 2032-02-01 | Ouvrir |
| NCT07796347 Dyadic Life Review Intervention for Older Patients With Advanced Cancer… |
Dyadic Life Review Intervention f… | Alzheimer | Non applicable | NOT_YET_RECRUITING | En attente / non publié | University of Rochester | United States · University of Rochester, Rochester, U… | 2026-10-01 → 2030-07-28 | Ouvrir |
| NCT06170788 TroFuse-007 — Sacituzumab Tirumotecan (MK-2870) in Combination With Pem… |
Sacituzumab Tirumotecan | Parkinson | Phase 3 | RECRUITING | En attente / non publié | Merck Sharp & Dohme LLC | United States, Argentina, Australia, Brazil, Canada, … | 2023-12-15 → 2030-05-27 | Ouvrir |
| NCT07216703 A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination Wi… |
Pembrolizumab | Parkinson | Phase 3 | RECRUITING | En attente / non publié | Merck Sharp & Dohme LLC | United States, Argentina, Austria, Belgium, Brazil, C… | 2026-01-19 → 2031-10-29 | Ouvrir |
| NCT07002034 RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Ot… |
RE104 for Injection | Sclérose latérale amyotrophique | Phase 2 | RECRUITING | En attente / non publié | Reunion Neuroscience Inc | United States · Alliance for Multispecialty Research … | 2025-07-30 → 2026-12 | Ouvrir |
| NCT04009863 HIFU Ablation vs Fixed-dose RAI-131 Therapy in Moderate-sized Non-toxic… |
Echopulse | Cancer | Non applicable | COMPLETED | En attente / non publié | The University of Hong Kong | Hong Kong · Queen Mary Hospital, Hong Kong, Hong Kong | 2020-04-01 → 2022-04-30 | Ouvrir |
| NCT03996005 MRI-TULSAP — MRI- Guided Transurethral Ultrasound Ablation of Localized… |
Magnetic Resonance Imaging-Guided… | Cancer | Non applicable | COMPLETED | En attente / non publié | University Hospital, Strasbourg, … | France · Hopitaux Universitaires de Strasbourg, Stras… | 2019-09-24 → 2023-07-25 | Ouvrir |
| NCT04791228 A Pilot Study of Thermodox and MR-HIFU for Treatment of Relapsed Solid … |
Magnetic Resonance-Guided High In… | Cancer | Phase 2 | WITHDRAWN | En attente / non publié | Children's National Research Inst… | United States · Children's National Hospital, Washing… | 2022-11-10 → 2024-12-23 | Ouvrir |
| NCT05363657 i-RECORd — International REgistry of COnservative or Radical Treatment … |
Partial Nephrectomy (PN) | Cancer | À vérifier | RECRUITING | En attente / non publié | Azienda Ospedaliero-Universitaria… | United States, Austria, Belgium, Brazil, Greece, Ital… | 2022-01-10 → 2028-12-31 | Ouvrir |
| NCT07376837 PTC-RFA — Radiofrequency Ablation for Curative Treatment of Small Low-R… |
Radiofrequency Ablation of Papill… | Cancer | Non applicable | RECRUITING | En attente / non publié | University Health Network, Toronto | Canada · University Health Network - Princess Margare… | 2026-02-05 → 2027-07-01 | Ouvrir |
| NCT03248375 Impact of Y90 Radiation Segmentectomy on HCC |
Radiation Segmentectomy | Cancer | Non applicable | COMPLETED | En attente / non publié | Icahn School of Medicine at Mount… | United States · Icahn School of Medicine at Mount Sin… | 2016-08-03 → 2021-03-31 | Ouvrir |
| NCT07628751 SOCRATES HCC — A Study of Standard Of Care Versus Radio Ablation in Ear… |
Stereotactic Ablative Body Radiot… | Cancer | Non applicable | RECRUITING | En attente / non publié | University Health Network, Toronto | Australia, Canada · Trans Tasman Radiation Oncology G… | 2026-05-11 → 2032-04-01 | Ouvrir |
| NCT04699773 LITT Followed by Hypofractionated RT for Newly Diagnosed Gliomas (GCC 2… |
LITT | Cancer | Non applicable | RECRUITING | En attente / non publié | University of Maryland, Baltimore | United States · Baltimore Washington Medical Center, … | 2021-02-20 → 2027-12 | Ouvrir |
| NCT02791503 CROSSFIRE Trial: Comparing the Efficacy of Irreversible Electroporation… |
Irreversible Electroporation (IRE) | Cancer | Non applicable | COMPLETED | En attente / non publié | Jewish General Hospital | Netherlands · Bart Geboers, Amsterdam, Netherlands | 2016-05-30 → 2022-09 | Ouvrir |
| NCT06205849 Intra-tumoral Mitazalimab (CD40 Antibody) With Irreversible Electropora… |
IRE + intratumoral mitazalimab (C… | Cancer | Phase 1 | RECRUITING | En attente / non publié | University of California, San Die… | United States · UCSD Moores Cancer Center, La Jolla, … | 2024-07-17 → 2030-08 | Ouvrir |
| NCT05660317 Assessment of Endoscopic Tip Control Using a Novel Score Based on the S… |
Assessment of Endoscopic Tip Cont… | Cancer | À vérifier | UNKNOWN | En attente / non publié | University Hospital, Ghent | Belgium · UZ Gent, Ghent, Belgium | 2022-09-01 → 2024-10-01 | Ouvrir |